Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.

Vascular health and risk management

Volumn 10, Issue , 2014, Pages 205-216

  Subedi, Bishnu H ^a   Joshi, Parag H ^a   Jones, Steven R ^a   Martin, Seth S ^a   Blaha, Michael J ^a   Michos, Erin D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECT; DYSLIPIDEMIA; GENE THERAPY; GENETICS; HIGH-DENSITY LIPOPROTEIN; HUMAN; LIPID METABOLISM; PRACTICE GUIDELINE; REVIEW; THERAPY; TREATMENT OUTCOME;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL; HIGH-DENSITY LIPOPROTEIN; LIPIDS; THERAPY;

BIOLOGICAL MARKERS; CHOLESTEROL, HDL; DYSLIPIDEMIAS; GENETIC THERAPY; HUMANS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIPOPROTEINS, HDL; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84904637406     PISSN: None     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Review

References (0)